Clinical Analysis of Pulmonary Nontuberculous Mycobacterial Disease Diagnosed as Coincidental Pulmonary Infection Due to Mycobacterium Species*


Objectives: We analyzed the clinical characteristics of patients with pulmonary mycobacterial disease diagnosed as coincidental pulmonary infection due to Mycobacterium species. Materials and Methods: One hundred sixty patients satisfied the diagnostic criteria of nontuberculous mycobacterial disease proposed by American Thoracic Society during the last seven years. Six patients (3.8%) were coincidental pulmonary infection due to two Mycobacterium species. We investigated the background, laboratory findings, microbiological findings, radiological findings, treatment and prognosis. Results: There were six patients, 3 males and 3 females, with a mean age of 71.7 years. The causative microorganisms of coincidental pulmonary infection consisted of Mycobacterium avium + Mycobacterium intracellulare in two patients, Mycobacterium avium + Mycobacterium kansasii in one, Mycobacterium intracellulare + Mycobacterium chelonae in one, Mycobacterium intracellulare + Mycobacterium abscessus in one, and Mycobacterium intracellulare + Mycobacterium tuberculosis in one. Regarding the radiological findings, the distribution of the lesion was frequently shown in both the right middle and left lingula lobes, but the extent of the lesion was limited within the unilateral lung field. Centrilobular small nodules with bronchiectasis were recognized in all patients and cavities or infiltration shadows were recognized in half of them on chest computed tomography. A definite diagnosis was obtained by bronchoalveolar lavage fluid in four patients and expectorated sputum in two. Combined chemotherapy was performed for two patients and that for pulmonary tuberculosis in one. Conclusions: Coincidental pulmonary infection due to Mycobactterium species occurred at a low percentage. Although most patients were elderly with underlying disease and clinical features were compatible with pulmonary Mycobacterium avium complex disease, the prognosis was comparatively good with and without treatment.

Share and Cite:

Kobashi, Y. , Mouri, K. , Obase, Y. , Kato, S. and Oka, M. (2013) Clinical Analysis of Pulmonary Nontuberculous Mycobacterial Disease Diagnosed as Coincidental Pulmonary Infection Due to Mycobacterium Species*. Open Journal of Respiratory Diseases, 3, 107-112. doi: 10.4236/ojrd.2013.32016.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] D. E. Griffith, T. Aksamit, B. A. Brown-Elliot, et al., “An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases,” American Journal of Respiratory and Critical Care Medicine, Vol. 175, No. 4, 2007, pp. 367-416. doi:10.1164/rccm.200604-571ST
[2] The Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis, The Scientific Assembly for Infection and Tuberculosis of the Japanese Respiratory Society, “Guideline for the Diagnosis of Pulmonary Nontuberculous Mycobacterial Diseases-2008,” Kekkaku, Vol. 86, No. 10, 2011, pp. 37-39.
[3] E. Sugihara, N. Hirota, T. Nizeki, et al., “Usefulness of Bronchial Lavage for the Diagnosis of Pulmonary Disease Caused by Mycobacterium avium-intracellulare Complex (MAC) Infection,” Journal of Infection and Chemotherapy, Vol. 9, No. 4, 2003, pp. 328-332. doi:10.1007/s10156-003-0267-1
[4] E. Tanaka, R. Amitani, A. Niimi, et al., “Yield of Computed Tomography and Bronchoscopy for the Diagnosis of Mycobacterium avium Complex Pulmonary Disease,” American Journal of Respiratory and Critical Care Medicine, Vol. 155, No. 6, 1997, pp. 2041-2046. doi:10.1164/ajrccm.155.6.9196113
[5] J. Jarand, A. Levin, L. Zhang, et al., “Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease,” Clinical Infectious Disease, Vol. 52, No. 5, 2011, pp. 565-571. doi:10.1093/cid/ciq237
[6] R. J. O’Brien, L. J. Geiter and D. E. Snider, “The Epidemiology of Nontuberculous Mycobacterial Diseases in the United States: Results from a National Survey,” American Review Respiratory Disease, Vol. 135, No. 5, 1987, pp. 1007-1014.
[7] D. E. Griffith, W. M. Girard and R. J. Wallace, Jr., “Clinical Features of Pulmonary Disease Caused by Rapidly Growing Mycobacteria: An Analysis of 154 Patients,” American Review Respiratory Disease, Vol. 147, No. 5, 1993, pp. 1271-1278. doi:10.1164/ajrccm/147.5.1271
[8] D. Han, K. S. Lee, W. J. Koh, et al., “Radiographic and CT Findings of Nontuberculous Mycobacterial Pulmonary Infection Caused by Mycobacterium abscessus,” American Journal of Roentgenology, Vol. 181, No. 2, 2003, pp. 513-517. doi:10.2214/ajr.181.2.1810513
[9] D. Shitrit, G. L. Baum, R. Pricess, et al., “Pulmonary Mycobacterium kansasii Infection in Israel, 1999-2004. Clinical Features, Drug Susceptibility, and Outcome,” Chest, Vol. 129, No. 3, 2006, pp. 771-776. doi:10.1378/chest.129.3.771
[10] Y. Kobashi and T. Matsushima, “The Microbiological and Clinical Effects of Combined Therapy According to Guidelines on the Treatment of Pulmonary Mycobacterium avium Complex Disease in Japan—Including a Follow-Up Study,” Respiration, Vol. 74, No. 4, 2007, pp. 394-400. doi:10.1159/000095674

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.